Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 1/20 | 0.56 |
| ▸ | ELOC | Q15369 | 1/20 | 0.56 |
| ▸ | ELOB | Q15370 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.52 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | NSD2 | O96028 | 1/20 | 0.48 |
| ▸ | GRK2 | P25098 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.48 |
| ▸ | AOC2 | O75106 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20649339 | 0.77 | KMT2A (0.59) | VHLELOCELOBENPP2MKNK1 | |
| SCHEMBL44284 | 0.73 | KDM4E (0.50) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL1366622 | 0.72 | L3MBTL1 (0.56) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL393880 | 0.72 | KDM4E (0.50) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL2239811 | 0.72 | ALDH1A1 (0.56) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL296099 | 0.72 | MAPT (0.56) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL196307 | 0.72 | NOTUM (0.52) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL5547132 | 0.72 | KDM4E (0.50) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL11822364 | 0.72 | KDM4E (0.50) | VHLELOCELOBKDM4EGAA | |
| SCHEMBL29201170 | 0.72 | MEN1 (0.43) | ENPP2MKNK1MKNK2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015183931-A1 | STABILIZED CHEMILUMINESCENT SYSTEM | LI-COR, INC. (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150346202-A1 | STABILIZED CHEMILUMINESCENT SYSTEM | Ll-COR, INC. (US) | 2015-12-03 | — | — | US | claimed |
| EP-4689159-A1 | METHOD AND KITS | Oxford Nanopore Technologies PLC (GB) | 2026-02-11 | — | — | EP | disclosed |
| US-12391781-B2 | Black particles, black coating material, coating film, and black matrix for color filters | SEKISUI CHEMICAL CO., LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-4063426-B1 | BLACK PARTICLES, BLACK COATING MATERIAL, COATING FILM, AND BLACK MATRIX FOR COLOR FILTERS | SEKISUI CHEMICAL CO LTD (JP) | 2025-06-18 | — | — | EP | disclosed |
| WO-2025070747-A1 | METHOD FOR MEASURING ANTIGEN CONTAINED IN TEST SAMPLE, AND KIT FOR MEASURING HUMAN CHORIONIC GONADOTROPIN OR ESTRADIOL | 富士フイルム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-4526468-A1 | METHOD AND ADAPTORS | Oxford Nanopore Technologies PLC (GB) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024200280-A1 | METHOD AND KITS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-10-03 | — | — | WO | disclosed |
| WO-2023222657-A1 | METHOD AND ADAPTORS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-11-23 | — | — | WO | disclosed |
| CN-114502677-B | Black particles, black paint, coating film, and black matrix for color filter | 积水化学工业株式会社 | 2023-11-14 | — | — | CN | disclosed |
| CN-116466091-A | Kit for detecting IgA immune complex based on chemiluminescence method | 深圳市陆为生物技术有限公司 | 2023-07-21 | — | — | CN | disclosed |
| WO-2003051841-A2 | COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051842-A2 | COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| EP-1311482-A2 | NON-IMIDAZOLE ARYLOXYPIPERIDINES AS H3 RECEPTOR LIGANDS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002044120-A1 | COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR III | KARO BIO AB (SE) | 2002-06-06 | — | — | WO | disclosed |
| US-20020040024-A1 | Non-imidazole aryloxypiperidines | NORTEL NETWORKS LIMITED (CA) | 2002-04-04 | — | — | US | disclosed |
| WO-2002012190-A2 | NON-IMIDAZOLE ARYLOXYPIPERIDINES AS H3 RECEPTOR LIGANDS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2002-02-14 | — | — | WO | disclosed |
| US-4072754-A | ANTICHOLESTEROL | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4016283-A | ADRENERGIC BLOCKING AGENTS | CIBA-GEIGY CORPORATION (US) | 1977-04-05 | — | — | US | disclosed |
| US-3984436-A | BLOCKERS OF ADRENERGIC B-RECEPTORS | CIBA-GEIGY CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040024-A1 | Non-imidazole aryloxypiperidines | HRH2, HRH4, HRH3 | VHL 1737/4885ELOC 3911/4885ELOB 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.